Erythromycin in renal failure. 1977

M S Wheeley

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M S Wheeley
March 1983, British medical journal (Clinical research ed.),
M S Wheeley
July 1984, American journal of kidney diseases : the official journal of the National Kidney Foundation,
M S Wheeley
April 1955, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
M S Wheeley
October 1982, Archives of internal medicine,
M S Wheeley
April 1980, Scottish medical journal,
M S Wheeley
April 1989, British journal of clinical pharmacology,
Copied contents to your clipboard!